Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1363 |
---|---|
Product Name | Anti-Human VEGFA Recombinant Antibody(Brolucizumab) |
Molecular Name | Brolucizumab |
Alias | Anti-VEGFA Recombinant Antibody, Research Grade Brolucizumab |
CAS Number | 1531589-13-5 |
Target | VEGFA[Homo sapiens] |
Isotype | scFv Kappa-heavy |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, IHC, IF, IP, FCM, Inhib |
Buffer | PBS, pH7.5 |
Background | Brolucizumab, sold under the trade name Beovu, is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |